» Articles » PMID: 39203424

Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Aug 29
PMID 39203424
Authors
Affiliations
Soon will be listed here.
Abstract

Probiotics are "live microorganisms which, when administered in adequate amount, confer health benefits on the host". They can be found in certain foods like yogurt and kefir and in dietary supplements. The introduction of bacterial derivatives has not only contributed to disease control but has also exhibited promising outcomes, such as improved survival rates, immune enhancement, and growth promotion effects. It is interesting to note that the efficacy of probiotics goes beyond the viability of the bacteria, giving rise to concepts like paraprobiotics, non-viable forms of probiotics, and postbiotics. Paraprobiotics offer various health benefits in children with intestinal dysbiosis, contributing to improved digestive health, immune function, and overall well-being. In this review, the potential of these therapeutic applications as alternatives to pharmacological agents for treating pediatric intestinal dysbiosis will be thoroughly evaluated. This includes an analysis of their efficacy, safety, long-term benefits, and their ability to restore gut microbiota balance, improve digestive health, enhance immune function, and reduce inflammation. The aim is to determine if these non-pharmacological interventions can effectively and safely manage intestinal dysbiosis in children, reducing the need for conventional medications and their side effects.

References
1.
Kolida S, Gibson G . Synbiotics in health and disease. Annu Rev Food Sci Technol. 2011; 2:373-93. DOI: 10.1146/annurev-food-022510-133739. View

2.
Sugihara K, Kamada N . Diet-Microbiota Interactions in Inflammatory Bowel Disease. Nutrients. 2021; 13(5). PMC: 8147260. DOI: 10.3390/nu13051533. View

3.
Rutayisire E, Huang K, Liu Y, Tao F . The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review. BMC Gastroenterol. 2016; 16(1):86. PMC: 4967522. DOI: 10.1186/s12876-016-0498-0. View

4.
Li M, Van Esch B, Wagenaar G, Garssen J, Folkerts G, Henricks P . Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018; 831:52-59. DOI: 10.1016/j.ejphar.2018.05.003. View

5.
Kuenzig M, Fung S, Marderfeld L, Mak J, Kaplan G, Ng S . Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology. 2022; 162(4):1147-1159.e4. DOI: 10.1053/j.gastro.2021.12.282. View